A Phase II Randomized Placebo-Controlled Study Investigating the Combination of Yiv-906 and Sorafenib (SORA) in HBV (+) Patients (pts) with Advanced Hepatocellular Carcinoma (HCC)
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined